CITIUS ONCOLOGY, INC. (CTOR) Operating cash flow 2022–2025
CITIUS ONCOLOGY, INC. (CTOR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.5MFY2025 · since FY2022: -$47,968 → -$5.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.5M | -4446.6% |
| FY2024 | $126,353 | +121.0% |
| FY2023 | -$601,304 | -1153.6% |
| FY2022 | -$47,968 | — |
Source: SEC XBRL filings · For reference only · Not investment advice